1998
DOI: 10.1002/(sici)1099-0690(199808)1998:8<1669::aid-ejoc1669>3.0.co;2-q
|View full text |Cite
|
Sign up to set email alerts
|

Effect ofp-Substitution of Aryl α-D-Mannosides on Inhibiting Mannose-Sensitive Adhesion ofEscherichia coli – Syntheses and Testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
19
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 12 publications
2
19
0
Order By: Relevance
“…A plot of the percentage inhibition against the concentration of inhibitor enabled the extrapolation of the half‐maximal inhibitory concentration (IC 50 , Figures 4, a and S4). The IC 50 of 1950 μ M for α‐ D ‐methyl mannose is in agreement with the literature IC 50 values of 1300–3900 μ M 41,42. Concentrations of discotic molecules higher than 500 μ M could not be achieved because of solubility limits.…”
Section: Resultssupporting
confidence: 90%
“…A plot of the percentage inhibition against the concentration of inhibitor enabled the extrapolation of the half‐maximal inhibitory concentration (IC 50 , Figures 4, a and S4). The IC 50 of 1950 μ M for α‐ D ‐methyl mannose is in agreement with the literature IC 50 values of 1300–3900 μ M 41,42. Concentrations of discotic molecules higher than 500 μ M could not be achieved because of solubility limits.…”
Section: Resultssupporting
confidence: 90%
“…In vitro assays, usually used for QSAR studies, include three major components: the biological receptor or target, the native ligand and the test compound. In hemmaglutination inhibition assay, widely applied to test antagonist of FimH‐mediated bacterial adhesion, the bacterial lectin FimH is the receptor, the native ligand is glycosylated cell surface and the test compound is structurally modified α‐ d ‐mannoside. Here, we tested the potency of the ester type of ferrocene–mannose conjugate ( 10 , 12 and 14 ) to efficiently inhibit type 1 fimbriated E. coli HB101 (pPKl4) from agglutinating guinea‐pig erythrocytes.…”
Section: Resultsmentioning
confidence: 99%
“…Variation of the p ‐substituent of phenyl mannosides had no big effect. It was shown that neither the reduction of the nitro group in p NPMan (leading to p APMan), nor its deletion (PMan) changed the compound's inhibitory potency to a great extent 67,68. While Sharon and co‐workers had reported a difference between PMan [RIP(PMan) MeMan = 40] and p NPMan [RIP( p NPMan) MeMan = 70], somewhat later this difference could not be confirmed (cf.…”
Section: Rational Design Of Carbohydrate Ligands For the Type 1 Fimentioning
confidence: 99%